These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26179207)

  • 1. The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming.
    Phan L; Chou PC; Velazquez-Torres G; Samudio I; Parreno K; Huang Y; Tseng C; Vu T; Gully C; Su CH; Wang E; Chen J; Choi HH; Fuentes-Mattei E; Shin JH; Shiang C; Grabiner B; Blonska M; Skerl S; Shao Y; Cody D; Delacerda J; Kingsley C; Webb D; Carlock C; Zhou Z; Hsieh YC; Lee J; Elliott A; Ramirez M; Bankson J; Hazle J; Wang Y; Li L; Weng S; Rizk N; Wen YY; Lin X; Wang H; Wang H; Zhang A; Xia X; Wu Y; Habra M; Yang W; Pusztai L; Yeung SC; Lee MH
    Nat Commun; 2015 Jul; 6():7530. PubMed ID: 26179207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability.
    Su CH; Zhao R; Zhang F; Qu C; Chen B; Feng YH; Phan L; Chen J; Wang H; Wang H; Yeung SC; Lee MH
    Cancer Res; 2011 Feb; 71(3):884-94. PubMed ID: 21135113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of 14-3-3σ is predictive of poor prognosis for patients with human uterine papillary serous carcinoma.
    Suzuki F; Nagase S; Suzuki K; Oba E; Hiroki E; Matsuda Y; Akahira J; Nishigori H; Sugiyama T; Otsuki T; Yoshinaga K; Takano T; Niikura H; Ito K; Sasano H; Yaegashi N
    Tohoku J Exp Med; 2013 Nov; 231(3):193-9. PubMed ID: 24201220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14-3-3σ Contributes to Radioresistance By Regulating DNA Repair and Cell Cycle via PARP1 and CHK2.
    Chen Y; Li Z; Dong Z; Beebe J; Yang K; Fu L; Zhang JT
    Mol Cancer Res; 2017 Apr; 15(4):418-428. PubMed ID: 28087741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCNA and JNK1-Stat3 pathways respectively promotes and inhibits diabetes-associated centrosome amplification by targeting at the ROCK1/14-3-3σ complex in human colon cancer HCT116 cells.
    Lu YC; Wang P; Wang J; Ma R; Lee SC
    J Cell Physiol; 2019 Jul; 234(7):11511-11523. PubMed ID: 30478982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing Filamin A Inhibits the Invasion and Migration of Breast Cancer Cells by Up-regulating 14-3-3σ.
    Ji ZM; Yang LL; Ni J; Xu SP; Yang C; Duan P; Lou LP; Ruan QR
    Curr Med Sci; 2018 Jun; 38(3):461-466. PubMed ID: 30074213
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Winter M; Rokavec M; Hermeking H
    Cancer Res; 2021 Jul; 81(13):3621-3634. PubMed ID: 34224368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 14-3-3σ downregulation suppresses ICC metastasis via impairing migration, invasion, and anoikis resistance of ICC cells.
    Yang Z; Jin Q; Hu W; Dai L; Xue Z; Man D; Zhou L; Xie H; Wu J; Zheng S
    Cancer Biomark; 2017 Jul; 19(3):313-325. PubMed ID: 28482619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis.
    Han J; Zhang Y; Xu J; Zhang T; Wang H; Wang Z; Jiang Y; Zhou L; Yang M; Hua Y; Cai Z
    Cancer Lett; 2021 Jan; 496():57-71. PubMed ID: 33038488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of 14-3-3σ with KCMF1 suppresses the proliferation and colony formation of human colon cancer stem cells.
    Zou J; Mi L; Yu XF; Dong J
    World J Gastroenterol; 2013 Jun; 19(24):3770-80. PubMed ID: 23840115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 14-3-3σ attenuates RhoGDI2-induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells.
    Kim IK; Park SM; Cho HJ; Baek KE; Nam IK; Park SH; Ryu KJ; Ryu J; Choi J; Hong SC; Kim JW; Lee CW; Kang SS; Yoo J
    Oncotarget; 2013 Nov; 4(11):2045-56. PubMed ID: 24185104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative cell cycle regulator 14-3-3sigma stabilizes p27 Kip1 by inhibiting the activity of PKB/Akt.
    Yang H; Zhang Y; Zhao R; Wen YY; Fournier K; Wu HB; Yang HY; Diaz J; Laronga C; Lee MH
    Oncogene; 2006 Aug; 25(33):4585-94. PubMed ID: 16532026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of the tumor suppressor protein 14-3-3sigma is a sporadic event in cancer of the breast.
    Moreira JM; Ohlsson G; Rank FE; Celis JE
    Mol Cell Proteomics; 2005 Apr; 4(4):555-69. PubMed ID: 15644556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wig-1 regulates cell cycle arrest and cell death through the p53 targets FAS and 14-3-3σ.
    Bersani C; Xu LD; Vilborg A; Lui WO; Wiman KG
    Oncogene; 2014 Aug; 33(35):4407-17. PubMed ID: 24469038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H19/miR-675-5p Targeting SFN Enhances the Invasion and Metastasis of Nasalpharyngeal Cancer Cells.
    Zhang T; Lei F; Jiang T; Xie L; Huang P; Li P; Huang Y; Tang X; Gong J; Lin Y; Cheng A; Huang W
    Curr Mol Pharmacol; 2019; 12(4):324-333. PubMed ID: 31677258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role of TGFß1 dependent 14-3-3σ phosphorylation at Ser69 and Ser74 in the regulation of gene transcription, stemness and radioresistance.
    Zakharchenko O; Cojoc M; Dubrovska A; Souchelnytskyi S
    PLoS One; 2013; 8(5):e65163. PubMed ID: 23741479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.
    Yoon NK; Seligson DB; Chia D; Elshimali Y; Sulur G; Li A; Horvath S; Maresh E; Mah V; Bose S; Bonavida B; Goodglick L
    Cancer Biomark; 2009; 5(4):215-24. PubMed ID: 19729831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP.
    Shen L; O'Shea JM; Kaadige MR; Cunha S; Wilde BR; Cohen AL; Welm AL; Ayer DE
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5425-30. PubMed ID: 25870263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic changes of TIMP-3, GSTP-1 and 14-3-3 sigma genes as indication of status of chronic inflammation and cancer.
    Wang YJ; He L; Yuan M; Tsang WW; Hao L; Wang M; Chow LW; Cheung MN; Liu Q; Ng EL; Loo WT; Chow CY; Bai LJ; Yang Z
    Int J Biol Markers; 2014 Sep; 29(3):e208-14. PubMed ID: 25041782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.